Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 1927-1932

  Fujikawa, Katsuhiko ^a   Shiraki, Katsuya ^a   Sugimoto, Kazushi ^a   Ito, Takeshi ^a   Yamanaka, Takenari ^a   Takase, Koujiro ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Caspase; CPP32; Hepatocellular carcinoma; ICE

Indexed keywords

CASPASE 3; ENZYME ANTIBODY; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 1; CASPASE 3; CASPASES; CYTOPLASM; ENZYME INDUCTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU NICK-END LABELING; LIVER; LIVER NEOPLASMS; NEOPLASM PROTEINS; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0033890808     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Carson DA and Ribeiro JM: Apoptosis and disease. Lancet 341: 1251-1254, 1993.
2. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995.
3. Hug H: Fas-mediated apoptosis in tumor formation and defense. Biol Chem 378: 1405-1412, 1997.
4. Thorgeirsson SS, Teramoto T and Factor VM: Dysregulation of apoptosis in hepatocellular carcinoma. Semin Liver Dis 18: 115-122, 1998.
5. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S and Peter ME: Apoptosis signaling by death receptor. Eur J Biochem 254: 439-459, 1998.
6. Rosen A and Casciola-Rosen L: Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem 64:50-54, 1997.
7. Yuan J, Shaham S, Ledoux S, Ellis HM and Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β converting enzyme. Cell 75: 641-652, 1993.
8. Fernandes-Alnemri T, Litwack G and Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β converting enzyme. J Biol Chem 269: 30761-30764, 1994.
9. Hasegawa J, Kamada S, Kamiike W, Shimizu S, Imazu T, Matsuda H and Tsujimoto Y: Involvement of CPP32/Yama(-like) protease in Fas-mediated apoptosis. Cancer Research 56: 1713-1718, 1996.
10. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT and Nicholson DW: CPP32/Apopain is a key interleukin 1 β converting enzyme-like protease involved in Fas-mediated apoptosis. J Biological Chemistry 271: 1841-1844, 1996.
11. Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, Kuni Y, Okamoto N, Inoue T and Kanisawa M: Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastoenterology 103: 595-600, 1992.
12. Kondo T, Suda T, Fukuyama H, Adachi M and Nagata S: Essential roles of the Fas ligand in the development of hepatitis. Nature Medicine 3: 409-413, 1997.
13. Kunstle G, Leist M. Uhlig S, Revesz L Feifel R, MacKenzie A and Wendel A: ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF- α. Immunol Lett 55: 5-10, 1997.
14. Natoli G, Ianni A, Costanzo A, De Petrillo G, Ilari I, Chirillo P, Balsano C and Levrero M: Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11: 1157-1164, 1995.
15. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH and Galle PR: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion? Nat Med 2: 1361-1366, 1996.
16. Yano H, Fukuda K, Haramaki M, Motosaki S, Ogasawara S, Higaki K, and Kojiro M: Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines. J Hepatol 25: 454-464, 1996.
17. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997.
18. Gavrieli Y, Sherrman Y, Ben Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell 199: 493-501, 1992.
19. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R and Reed JC: Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res 57: 1605-1613, 1997.
20. Seino K, Kayagaki N, Takeda K, Fukao K and Okumura K, Yagita H: Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113: 1315-1322, 1997.
21. Galle PG and Krammer PH: CD95-induced apoptosis in human liver disease. SeminLiver Dis 18: 141-151, 1998.
22. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16.
23. Duriez PJ and Shah GM: Cleavage of poly (ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 75: 337-349, 1997.
24. Hallan E, Blomhoff K, Smeland E-B and Lomo J: Involvement of ICE (Caspase) family in y-radiation-induced apoptosis of normal B lymphocytes. Scand J Immunol 46: 601-608, 1997.
25. Jiang S, Song MJ, Shin EC, Lee MO, Kim SJ and Park JH: Apoptosis in human cell lines by chemotherapeutic drugs via fas-dependent and fas independent pathways. Hepatology 29: 101-110, 1999.
26. Chhanabhai M, Krajewaki S, Krajewska M, Wang HG, Reed JC and Gascoyne RD: Immunohistochemical analysis of interleukin-1β-converting enzyme/Ced-3 Family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease. Blood 90: 2451-2455, 1997.
27. Hoshi T, Sasano H, Kato K, Yabuki N, Ohara S, Konno R, Asaki S, Toyota T, Tateno H and Nagura H: Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 18: 4347-4354, 1998.
28. Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MSS, Zhao H, Cnaan A and Sakiyama S: High levels of expression and nuclear localization of interleukin-1 β converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res 57: 4578-4584, 1997.
29. Gansauge S, Gansauge F, Yang Y, Müller J, Sefferlein T, Ramadani M and Beger HB: Interleukin 1 β-converting enzyme(Caspase-1) is over expressed in adenocarcinoma of the pancreas. Cancer Res 58:2703-2706, 1998.
30. Adjei PN, Kaufmann SH, Leung WY, Mao F and Geores GJ: Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for protease-dependent pathway that does not activate cysteine protease P32. J Clin Invest 98: 2588-2596, 1996.
31. Zhao M, Zhang NX, Economou M, Blaha I and Laissue JA: Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 25: 237-245, 1994.
32. Deveraux QL, Takahashi R, Salvesen GS and Reed JC: X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304, 1997.
33. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin inhibitors caspase activity and apoptosis induced by Fas (CD95), bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320, 1998.